Evaluating the serum fibrinogen level as a biomarker of disease severity in stable non-cystic fibrosis bronchiectasis Cover

.blurhash-client-img { display: none !important; }

Evaluating the serum fibrinogen level as a biomarker of disease severity in stable non-cystic fibrosis bronchiectasis

Volume 73 (2024): Issue 1 (January 2024)

By: Doaa Gadallah, Ahmed Tawfeek and Shimaa Nour Morsi

Open Access

|Apr 2025

Metrics

DOI: https://doi.org/10.2478/pneum-2025-0005 | Journal eISSN: 2247-059X | Journal ISSN: 2067-2993

Journal RSS Feed

Language: English

Page range: 26 - 35

Published on: Apr 24, 2025

Published by: Romanian Society of Pneumology

In partnership with: Paradigm Publishing Services

Publication frequency: Volume open

Keywords:

serum fibrinogen,

stable non-cystic fibrosis bronchiectasis,

bronchiectasis severity index

Related subjects:

Clinical medicine,

Clinical medicine, other,

Internal medicine,

© 2025 Doaa Gadallah, Ahmed Tawfeek, Shimaa Nour Morsi, published by Romanian Society of Pneumology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 73 (2024): Issue 1 (January 2024)Next article